115 related articles for article (PubMed ID: 6277797)
1. Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients.
Crawford DH; Edwards JM; Sweny P; Hoffbrand AV; Janossy G
Int J Cancer; 1981 Dec; 28(6):705-9. PubMed ID: 6277797
[TBL] [Abstract][Full Text] [Related]
2. Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A.
Crawford DH; Sweny P; Edwards JM; Janossy G; Hoffbrand AV
Lancet; 1981 Jan; 1(8210):10-2. PubMed ID: 6109048
[TBL] [Abstract][Full Text] [Related]
3. Immunity to Epstein-Barr virus in cyclosporin A-treated renal allograft recipients.
Crawford DH; Edwards JM
Lancet; 1982 Jun; 1(8287):1469-70. PubMed ID: 6123746
[No Abstract] [Full Text] [Related]
4. In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients.
Yao QY; Rickinson AB; Gaston JS; Epstein MA
Int J Cancer; 1985 Jan; 35(1):43-9. PubMed ID: 2981781
[TBL] [Abstract][Full Text] [Related]
5. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.
Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL
Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304
[TBL] [Abstract][Full Text] [Related]
6. Effect of herpesvirus infections on T-lymphocyte subpopulations and blastogenic responses in renal transplant recipients receiving cyclosporine.
Rinaldo CR; DeBiasio RL; Hamoudi WH; Rabin B; Liebert M; Hakala TR
Clin Immunol Immunopathol; 1986 Mar; 38(3):357-66. PubMed ID: 3002696
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.
Wilkinson AH; Smith JL; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ
Transplantation; 1989 Feb; 47(2):293-6. PubMed ID: 2645716
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr-virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression.
Gaston JS; Rickinson AB; Epstein MA
Lancet; 1982 Apr; 1(8278):923-5. PubMed ID: 6122768
[TBL] [Abstract][Full Text] [Related]
9. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.
Rickinson AB; Rowe M; Hart IJ; Yao QY; Henderson LE; Rabin H; Epstein MA
Cell Immunol; 1984 Sep; 87(2):646-58. PubMed ID: 6088089
[TBL] [Abstract][Full Text] [Related]
10. [A case of malignant lymphoma after renal transplantation].
Oyama H; Yamao K; Sugiyama T; Matsuura O; Murakami S; Ikeda K; Inoue S
No Shinkei Geka; 1997 Jul; 25(7):655-60. PubMed ID: 9218261
[TBL] [Abstract][Full Text] [Related]
11. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
Sumpio BE; Dwyer JM; Flye MW
Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
13. [Kaposi's sarcoma in kidney transplant treated with cyclosporin and azathioprine].
Cózar JM; Martínez Piñeiro L; Avellana JA; de la Peña J; Hidalgo L; Sanz A; Burgos F; Martínez Piñeiro JA
Arch Esp Urol; 1990 Mar; 43(2):155-8. PubMed ID: 2363579
[TBL] [Abstract][Full Text] [Related]
14. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.
Moss DJ; Rickinson AB; Pope JH
Int J Cancer; 1978 Dec; 22(6):662-8. PubMed ID: 214405
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine.
Bunney MH; Benton EC; Barr BB; Smith IW; Anderton JL; Hunter JA
Nephrol Dial Transplant; 1990; 5(5):379-82. PubMed ID: 2165226
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control.
Gunapala DE; Facer CA; Davidson R; Weir WR
Parasitol Res; 1990; 76(6):531-5. PubMed ID: 2166284
[TBL] [Abstract][Full Text] [Related]
17. Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.
Crawford DH; Thomas JA; Janossy G; Sweny P; Fernando ON; Moorhead JF; Thompson JH
Lancet; 1980 Jun; 1(8182):1355-6. PubMed ID: 6104142
[No Abstract] [Full Text] [Related]
18. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
[No Abstract] [Full Text] [Related]
19. The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts.
Sweny P; Tidman N
Clin Exp Immunol; 1982 Feb; 47(2):445-8. PubMed ID: 6210475
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection and immunity in bone marrow transplant recipients.
Crawford DH; Mulholland N; Iliescu V; Hawkins R; Powles R
Transplantation; 1986 Jul; 42(1):50-4. PubMed ID: 3014694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
